Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Translational Oncology|July 29, 2023
Receptor-interacting protein kinase 1 (RIPK1) regulates cervical cancer cells via NF-κB-TNF-α pathway: An in vitro studyWenqi Bai, Fengjie Cui, Zihan Wang, et al.
Journal of Cancer Research and Clinical Oncology|January 29, 2024
Exploring the expression and clinical significance of the miR-140-3p-HOXA9 axis in colorectal cancerWei Cui, Xueliang Bai, Zhongyuan Bai, et al.
Pharmacogenomics and Personalized Medicine|April 8, 2024
Exploration of the Correlation Between <i>GRHL1</i> Expression and Tumor Microenvironment in Endometrial Cancer and ImmunotherapySuyang Guo, Wenqi Bai, Fengjie Cui, et al.
Frontiers in Neurorobotics|December 15, 2022
UVMS task-priority planning framework for underwater task goal classification optimizationYu-Er Gao, Xiaohui Zhang, Yan Su, et al.
Frontiers in Cell and Developmental Biology|October 15, 2025
Single-cell and bulk RNA-sequencing reveal PRRX2-driven cancer-associated fibroblast-mediated perineural invasion for predicting the immunotherapy outcome in colorectal cancerMingxiao Chen, Yue Cai, Feng Han, et al.
Cancer Medicine|April 5, 2019
Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patientsWenqi Bai, Jinfeng Ma, Yangyang Liu, et al.
Experimental and Molecular Pathology|August 2, 2015
Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphomaYanfeng Xi, Jing Li, Ping Zhang, et al.
Translational Cancer Research|June 12, 2023
Clinicopathological and prognosis significance of RIPK1 in patients with cervical squamous cell carcinoma: a retrospective cohort studySuyang Guo, Wenqi Bai, Xianhua Gu, et al.
Frontiers in Genetics|October 27, 2022
Endometrial cancer prognosis prediction using correlation models based on CDK family genesXianhua Gu, Honghong Shen, Wenqi Bai, et al.
Future Oncology (London, England)|October 12, 2023
siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathwayYanling Yu, Dimitri Papukashvili, Ruimin Ren, et al.
Pageof 4